International Medica Foundation Reaches Final Vaccination Milestone in Phase II Clinical Trial for Rotavirus Vaccine
1/14/2010 10:44:42 AM
ROCHESTER, Minn.--(BUSINESS WIRE)--Rotavirus is responsible for the deaths of more than 1,500 infants and children daily, mainly in developing countries. To combat this killer of children, the International Medica Foundation is sponsoring a Phase II clinical trial of its oral rotavirus vaccine, RotaShield®.
comments powered by